Clinical Trial Update: Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis. [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating the efficacy and safety of VC005 tablets in subjects with active ankylosing spondylitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• VC005

Snippet

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD | Conditions: Active Ankylosing Spondylitis | Phase 2 | Status: COMPLETED